Age for diabetes screening should be reduced to 35: USPSTF draft recommenation

The lower baseline age for screening, which carries a B grade, is a "major change" from the 2015 final USPSTF recommendation in this clinical area, said Chien-Wen Tseng, a task force member and research director in the department of family medicine and community health at the University of Hawaii John A. Burns School of Medicine. She added that changes in epidemiological data prompted the revised recommendation.

The USPSTF, citing CDC data, said 34.5% of all U.S. adults meet criteria for prediabetes and 13% of all U.S. adults have diabetes. Among the latter group, 21.4% did not know they had the disease or did not report having it. In addition, only 15.3% of adults with prediabetes said a health professional notified them of their status.

The authors of a related evidence review wrote that criteria for prediabetes includes impaired fasting glucose, impaired glucose tolerance and a glycated hemoglobin ranging from 5.7% to 6.4%, while type 2 diabetes is characterized as having insulin resistance and relative insulin deficiency.

"Trials of screening for diabetes found no mortality benefit at 10 years but had insufficient data to assess other health outcomes. Evidence on harms of screening was scant. For people with screendetected diabetes, one trial found no improvement in health outcomes over 5 to 10 years. For people with recently diagnosed (not screen-detected) diabetes, interventions improved health outcomes over 10 to 20 years," wrote the authors.

"For obese or overweight people with prediabetes, interventions were associated with reduced incidence of diabetes and improvement in other intermediate outcomes, and limited evidence suggests that very high-contact lifestyle interventions improve health outcomes after more than 20 years."

Reference:

Screening for Prediabetes and Type 2 Diabetes Mellitus